141. Deputy Seán Ó Fearghaíl asked the Minister for Health if she will address concerns outlined in correspondence (details supplied) regarding the treatment of Duchenne muscular dystrophy; and if she will make a statement on the matter. [32876/25]
Topics / Medicinal Products
A subject heading for parliamentary questionsMedicinal Products
1,233 questions from 132 TDs, between 22 January 2025 and 22 October 2026.
1,233
questions
1,229 written, 4 oral
132
TDs have asked
11
parties and groups
Independents counted together
4
departments asked
Questions per month
The record holds no questions for August, when the Dáil does not sit.
Jan 2025Oct 2026
Show as a table
| Month | Questions |
|---|---|
| January 2025 | 17 |
| February 2025 | 66 |
| March 2025 | 28 |
| April 2025 | 35 |
| May 2025 | 43 |
| June 2025 | 58 |
| July 2025 | 56 |
| August 2025 | 0 |
| September 2025 | 36 |
| October 2025 | 38 |
| November 2025 | 58 |
| December 2025 | 27 |
| January 2026 | 18 |
| February 2026 | 70 |
| March 2026 | 142 |
| April 2026 | 87 |
| May 2026 | 156 |
| June 2026 | 127 |
| July 2026 | 82 |
| August 2026 | 0 |
| September 2026 | 62 |
| October 2026 | 27 |
Who asks, by party
The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.
The TDs who asked most
Members of the Government answer questions rather than ask them. Each question counts once.
-
196
-
75
-
43
-
42
-
39
-
26
-
26
-
26
Asked of
Debated under the same heading
Debates whose official heading is exactly these words.
The questions
143. Deputy Mark Ward asked the Minister for Health if she will meet members of the group who made a presentation on Duchenne muscular dystrophy on 11 June 2025 in Leinster House as they try to access a new drug called givinostat; and if she will make a statement on the matter. [32910/25]
150. Deputy Brendan Smith asked the Minister for Health to report on the progress being made regarding the provision of givinostat (brand name duvyzat) for the treatment of Duchenne muscular dystrophy; and if she will make a statement on the matter. [32923/25]
153. Deputy Eoin Hayes asked the Minister for Health when all adults living with spinal muscular atrophy will be entitled to the same treatments as children living with spinal muscular atrophy in Ireland; and if she will make a statement on the matter. [32936/25]
156. Deputy Claire Kerrane asked the Minister for Health if she will seek access to the early access programme for givinostat for patients with Duchenne muscular dystrophy; and if she will make a statement on the matter. [33019/25]
165. Deputy Claire Kerrane asked the Minister for Health if patients with Duchenne muscular dystrophy will have access to the early access programme for givinostat; and if she will make a statement on the matter. [33077/25]
167. Deputy Roderic O'Gorman asked the Minister for Health to provide an update on the health technology assessment being carried out on the orphan medicine givinostat (brand name duvyzat) used to treat Duchenne muscular dystrophy; if there are any steps she can take to speed up the assessment process; and if she will make a statement on the matter. [33092/25]
741. Deputy Cathal Crowe asked the Minister for Health when the medication known as givinostat will be made available in Ireland, given its potential role in the treatment of Duchenne muscular dystrophy; and if she will make a statement on the matter. [31801/25]
746. Deputy Richard Boyd Barrett asked the Minister for Health whether she will intervene to ensure that a person (details supplied) with Duchenne muscular dystrophy can be prescribed givnostat as a matter of urgency. [31826/25]
747. Deputy Michael Healy-Rae asked the Minister for Health if the drug givinostat will be approved in Ireland (details supplied); and if she will make a statement on the matter. [31827/25]
759. Deputy Erin McGreehan asked the Minister for Health if she will provide details regarding the prescribing of antidepressants to patients who are covered under the medical card scheme and the drugs payment scheme; and if she will make a statement on the matter. [31852/25]
773. Deputy John Brady asked the Minister for Health if she will make the drug givinostat available to all who are diagnosed with Duchenne Muscular Dystrophy; if so, whether she will provide a timeline for the rollout of this drug; and if she will make a statement on the matter. [31934/25]
807. Deputy Shane Moynihan asked the Minister for Health when medication known as givinostat will be made available in the State, given the role it can play in treating Duchenne muscular dystrophy in young boys. [32084/25]
827. Deputy Seán Canney asked the Minister for Health if she will expedite the process of approval for givinostat, used in the treatment of Duchenne Muscular Dystrophy, as further delays could affect the ability of patients to retain muscular strength and the current process for drug approval in Ireland can take on average 617 days, during which time muscular dystrophy patients will have lost significant muscle stren…
833. Deputy Cian O'Callaghan asked the Minister for Health if she will ensure that a new medication (details supplied) is processed on the HSE reimbursement list as quickly as possible when it is given EU approval; if she will take action to make this medication available for all children with Duchenne Muscular Dystrophy; and if she will make a statement on the matter. [32302/25]
858. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to the concerns of pharmacists regarding the prohibitive cost of the shingles vaccine, despite it being recommended by the National Immunisation Advisory Committee; if her Department has engaged with the manufacturer in any way to seek a reduction in price per unit; and if she will make a statement on the matter. [32385/25]
861. Deputy Ged Nash asked the Minister for Health if she is aware of the issues Duchenne muscular dystrophy patients are having getting timey access to a new drug for the condition (details supplied); if immediate steps will be taken to make this drug available; and if she will make a statement on the matter. [32396/25]
870. Deputy Cormac Devlin asked the Minister for Health the status of consideration, use (even on a trial basis), and funding for the drug givinostat for Duchenne muscular dystrophy; and if she will make a statement on the matter. [32461/25]
882. Deputy Paul Donnelly asked the Minister for Health if there are plans to further roll out the free HRT scheme to men and others who use HRT for medical reasons. [32518/25]
885. Deputy Liam Quaide asked the Minister for Health her plans to make eylea or aflibercept, available to suitable patients in Irish hospitals for the treatment of the wet form of age-related macular degeneration; and if she will make a statement on the matter. [32555/25]
923. Deputy Darren O'Rourke asked the Minister for Health if she is considering an early access programme to givinostat (details supplied) for Duchenne muscular dystrophy patients in Ireland, similar to that provided in Scotland; and if she will make a statement on the matter. [32733/25]
924. Deputy Darren O'Rourke asked the Minister for Health if she is considering providing access to fivinostat for non-ambulant Duchenne muscular dystrophy patients in Ireland in addition to ambulant patients; and if she will make a statement on the matter. [32734/25]
931. Deputy Pádraig Rice asked the Minister for Health the steps she will take to ensure that adults with spinal muscular atrophy receive access to approved medicines (details supplied); if she will engage in dialogue with stakeholders regarding the current age-based exclusion; and if she will make a statement on the matter. [32774/25]
939. Deputy Eoghan Kenny asked the Minister for Health if she has given consideration to a fast-tracked review of vyloy for inclusion in the HSE reimbursement scheme; and if she will make a statement on the matter. [32811/25]
940. Deputy Ryan O'Meara asked the Minister for Health if the drug, victoza, also known as liraglutide, is available under the drugs payment scheme (DPS) for patients who have had it prescribed for weight loss; if not, whether there are alternatives available under the DPS that a patient may instead discuss with their GP; and if she will make a statement on the matter. [32817/25]